Previous Close | 0.7730 |
Open | 0.7880 |
Bid | 0.8331 x 200 |
Ask | 0.9010 x 200 |
Day's Range | 0.7801 - 0.8800 |
52 Week Range | 0.7500 - 8.0100 |
Volume | |
Avg. Volume | 916,770 |
Market Cap | 82.309M |
Beta (5Y Monthly) | 1.00 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -4.6700 |
Earnings Date | May 07, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.00 |
LAKE FOREST, Ill., April 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced effectiveness of the appointment of Sigurd (Sig) Kirk to its board of directors. He will serve on the Audit and Compensation committees. Kirk is a senior corporate business development executive with more than 20 years of pharmaceutical experienc
LAKE FOREST, Ill., April 01, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that Ajay Patel, Chief Financial Officer, will present at the LD Micro Invitational XIV Conference to be held April 9, 2024 in New York City. The Company will host a group presentation at 4:00 pm Eastern Time, and be available for individual meet
Today is shaping up negative for Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders, with the analysts delivering a...